Discovery of a potent M antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonists.

Bioorg Med Chem Lett

Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address:

Published: December 2022

This Letter describes our ongoing effort to improve the clearance of selective M antagonists. Herein, we report the replacement of the previously disclosed piperidine amide (4, disclosed in Part 1) with a pyrrolidine amide core. Several compounds within this series provided good potency, subtype selectivity, and low to moderate clearance profiles. Interestingly, the left-hand side SAR for this series diverged from our earlier efforts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938303PMC
http://dx.doi.org/10.1016/j.bmcl.2022.129021DOI Listing

Publication Analysis

Top Keywords

discovery potent
4
potent antagonist
4
antagonist improved
4
improved clearance
4
clearance profile
4
profile pyrrolidine
4
pyrrolidine amide-based
4
amide-based antagonists
4
antagonists letter
4
letter describes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!